By Connor Hart
Delta Air Lines lowered its first-quarter outlook, citing reduced consumer and corporate confidence amid economic uncertainty. The airline now expects adjusted per-share earnings of 30 cents to 50 cents and for revenue to rise 3% to 4% from a year ago, compared with a prior outlook for adjusted per-share earnings of 70 cents to $1 and for revenue to rise 7% to 9%. Delta said that domestic travel is most heavily affected. Shares fall 11%, to $44.70, in after-hours trading.
Oracle's fiscal third-quarter results missed expectations, though the cloud-services offered an upbeat sales outlook as it aims to double its data center capacity this year. The company reported adjusted earnings of $1.47 a share on revenue of $14.13 billion, missing analyst forecasts for adjusted earnings of $1.49 a share on revenue of $14.38 billion. For the current quarter, Oracle expects revenue to grow 9% to 11%, with total cloud revenue jumping between 24% and 28%. Shares fall 3.4%, to $143.77, in postmarket trading.
LifeMD's fourth-quarter financial results topped analyst expectations. The telehealth company posted a per-share loss of 2 cents, ahead of the 7-cent loss that analysts modeled. Revenue of $64.3 million topped analyst views for $57.5 million. The company guided for sales of $265 million to $275 million in 2025, above the $258 million that analysts were looking for. Shares jump 25%, to $5.35, in after-hours trading.
Tenon Medical received notice of two approvals from the European patent office. The medical-device maker after the bell said two additional patents related to its Catamaran Sacroiliac Joint Fixation Device have been approved for grant of a European patent within the European Community. Shares rise 44%, to $1.80, in postmarket trading.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
March 10, 2025 19:31 ET (23:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。